Metabolic diseases and their possible link to risk indicators of periodontitis.

BACKGROUND During the last few years, risk assessment has become one of the main topics of periodontal research. Therefore, the aim of this study was to determine whether a predisposition to metabolic disorders such as diabetes mellitus (in the absence of diagnosed diabetic disease) or hyperlipidemia may be risk indicators for periodontitis. METHODS One hundred patients ranging in age from 40 to 70 years were examined. The patients were classified as having impaired glucose tolerance (IGT) but no manifest diabetes (56 patients), hyperlipidemia (17 patients, HL), or normal metabolic status (27 control patients). Probing depth (PD), attachment level (AL), plaque index (PI), and gingival bleeding on probing (BOP) were recorded. Serum antibody titers (SAT) to A. actinomycetemcomitans (A.a.), P. intermedia (P.i.), and P. gingivalis (P.g.) were determined by enzyme-linked immunosorbent assay (ELISA). Pooled subgingival plaque samples were analyzed using indirect immunofluorescence to detect the same organisms. In addition, respiratory burst activity of peripheral polymorphonuclear leukocytes (PMN) was evaluated by chemiluminescence (CL). RESULTS No significant differences were observed between the IGT group and normal controls in the following parameters: 1) percentage of sites exhibiting BOP; 2) mean PI; 3) mean PD and AL; 4) percentage of periodontal microorganisms; and 5) increased SAT. The IGT probands exhibited a significantly higher mean serum level of triglycerides, as well as higher formyl-methionyl-leucyl-phenylalanine (FMLP)-stimulated PMN chemiluminescence than the control group. Patients with hyperlipidemia (HL) showed a significantly higher number of sextants with increased PD (73.4%) than the control group (50.6%). Similar results were obtained when comparing the percentage of all sites with increased PD (HL = 16.7%, control 12.3%). The mean FMLP-stimulated CL in patients with hyperlipidemia was significantly higher than the control group. When looking at all patients, there was a small but statistically significant correlation between PD and lipid levels. In addition, a significant correlation was observed between lipid serum levels and the FMLP-stimulated chemiluminescence. CONCLUSIONS These findings suggest that abnormal glucose tolerance, which is a predisposing factor for diabetes mellitus, does not appear to be a risk indicator for periodontal disease. On the other hand, impaired lipid metabolism does seem to be a risk indicator for periodontitis.

[1]  J. Beck,et al.  Periodontal Infection as a Possible Risk Factor for Preterm Low Birth Weight. , 1996, Journal of periodontology.

[2]  J. Beck,et al.  Influence of risk factors on the pathogenesis of periodontitis. , 1997, Periodontology 2000.

[3]  A. Iacopino,et al.  Diabetic periodontitis: possible lipid-induced defect in tissue repair through alteration of macrophage phenotype and function. , 2008, Oral diseases.

[4]  M. Cattabriga [Etiology and prevention of periodontal diseases]. , 1978, Rivista italiana di stomatologia.

[5]  J. Ship,et al.  Oral Health in Patients With Type II Diabetes and Impaired Glucose Tolerance , 1993, Diabetes Care.

[6]  L. Wolff,et al.  Bacteria as Risk Markers for Periodontitis. , 1994, Journal of periodontology.

[7]  W. Knowler,et al.  Severe Periodontitis and Risk for Poor Glycemic Control in Patients with Non-Insulin-Dependent Diabetes Mellitus. , 1996, Journal of periodontology.

[8]  M. Nieminen,et al.  Association between dental health and acute myocardial infarction. , 1989, BMJ.

[9]  Wilson Wr,et al.  Leukocyte chemotaxis in diabetic patients and their nondiabetic first-degree relatives. , 1976 .

[10]  S. Nares,et al.  In vitro alteration of macrophage phenotype and function by serum lipids , 1999, Cell and Tissue Research.

[11]  A Voller,et al.  Enzyme immunoassays in diagnostic medicine. Theory and practice. , 1976, Bulletin of the World Health Organization.

[12]  S. Kopprasch,et al.  Comparison of circulating phagocyte oxidative activity measured by chemiluminescence in whole blood and isolated polymorphonuclear leukocytes. , 1996, Clinica chimica acta; international journal of clinical chemistry.

[13]  P. Vokonas,et al.  Periodontal Disease and Cardiovascular Disease. , 1996, Journal of periodontology.

[14]  J. Beck,et al.  Methods of Assessing Risk for Periodontitis and Developing Multifactorial Models. , 1994, Journal of periodontology.

[15]  R. Genco,et al.  Rapid Identification of Periodontal Pathogens in Subgingival Dental Plaque: Comparison of Indirect Immunofluorescence Microscopy with Bacterial Culture for Detection of Bacteroides gingivalis. , 1985, Journal of periodontology.

[16]  R. Genco,et al.  Current View of Risk Factors for Periodontal Diseases. , 1996, Journal of periodontology.

[17]  T. Tervonen,et al.  Diabetes-A Risk Factor for Periodontitis in Adults? , 1994, Journal of periodontology.

[18]  R. Genco,et al.  Periodontal disease in non-insulin-dependent diabetes mellitus. , 1991, Journal of periodontology.

[19]  G. Duff,et al.  The interleukin-1 genotype as a severity factor in adult periodontal disease. , 1997, Journal of clinical periodontology.

[20]  R. Page,et al.  Risk assessment for periodontal diseases. , 1997, International dental journal.

[21]  H. Löe,et al.  PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION. , 1964, Acta odontologica Scandinavica.

[22]  R. Genco Periodontal disease and risk for myocardial infarction and cardiovascular disease , 1998 .

[23]  J. Greenspoon Oral glucose tolerance test. , 1988, Mayo Clinic proceedings.

[24]  R. Genco,et al.  Neutrophil chemotaxis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus. , 1981, Journal of periodontology.

[25]  C. Cutler,et al.  Diabetes-induced impairment of macrophage cytokine release in a rat model: potential role of serum lipids. , 1998, Life sciences.

[26]  R. Page,et al.  Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. , 1997, Periodontology 2000.

[27]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[28]  R. Genco,et al.  Response to Periodontal Therapy in Diabetics and Smokers. , 1996, Journal of periodontology.

[29]  D. Williamson,et al.  Dental disease and risk of coronary heart disease and mortality. , 1993, BMJ.